Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › xenon

xenon

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of xenon

2 trials tracked of xenon: 2 in phase 3 or 4.

2Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2
  1. Phase 3 Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery Completed
  2. Phase 3 Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Xenon shows strongest evidence for neuroprotection against ischemic stroke and hypoxic-ischemic brain injury
Drug Pipeline Sys. Review
Xenon shows strongest evidence for neuroprotection against ischemic stroke and hypoxic-ischemic brain injury Noble gases show promise in protecting brains after stroke
This narrative review synthesizes preclinical and early clinical evidence regarding the neuroprotective effects of noble gases, specifically…
Research into noble gases like xenon suggests they may protect brain cells from damage caused by strokes and other types of head injuries.
Frontiers Aug 24, 2026